OraSure Technologies Inc (OSUR) - Total Assets
Based on the latest financial reports, OraSure Technologies Inc (OSUR) holds total assets worth $403.17 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
OraSure Technologies Inc - Total Assets Trend (1989–2025)
This chart illustrates how OraSure Technologies Inc's total assets have evolved over time, based on quarterly financial data. Also see OraSure Technologies Inc (OSUR) market capitalisation for the company's overall valuation and market capitalisation.
OraSure Technologies Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
OraSure Technologies Inc's total assets of $403.17 Million consist of 65.0% current assets and 35.0% non-current assets. Review OSUR total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.1% |
| Accounts Receivable | $22.20K | 0.0% |
| Inventory | $31.06K | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $19.05K | 0.0% |
| Goodwill | $43.36K | 0.0% |
Asset Composition Trend (1989–2025)
This chart illustrates how OraSure Technologies Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See OSUR share price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: OraSure Technologies Inc's current assets represent 65.0% of total assets in 2025, a decrease from 76.5% in 1989.
- Cash Position: Cash and equivalents constituted 0.1% of total assets in 2025, down from 60.5% in 1989.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 6.0% in 1989.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
OraSure Technologies Inc Competitors by Total Assets
Key competitors of OraSure Technologies Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.68 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
Shenyang Xingqi Pharmaceutical Co Ltd
SHE:300573
|
China | CN¥2.42 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
Visco Vision Inc.
TW:6782
|
Taiwan | NT$5.82 Billion |
|
QITIAN Technology Group Co Ltd
SHE:300061
|
China | CN¥1.17 Billion |
|
Embecta Corp
NASDAQ:EMBC
|
USA | $1.27 Billion |
OraSure Technologies Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.58 | 9.95 | 6.55 |
| Quick Ratio | 6.58 | 8.93 | 5.65 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $222.11 Million | $299.74 Million | $247.77 Million |
OraSure Technologies Inc - Advanced Valuation Insights
This section examines the relationship between OraSure Technologies Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.62 |
| Latest Market Cap to Assets Ratio | 0.53 |
| Asset Growth Rate (YoY) | -15.9% |
| Total Assets | $403.17 Million |
| Market Capitalization | $212.91 Million USD |
Valuation Analysis
Below Book Valuation: The market values OraSure Technologies Inc's assets below their book value (0.53x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: OraSure Technologies Inc's assets decreased by 15.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for OraSure Technologies Inc (1989–2025)
The table below shows the annual total assets of OraSure Technologies Inc from 1989 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $403.17 Million | -15.95% |
| 2024-12-31 | $479.66 Million | -0.66% |
| 2023-12-31 | $482.85 Million | +8.70% |
| 2022-12-31 | $444.18 Million | -3.65% |
| 2021-12-31 | $460.99 Million | +1.43% |
| 2020-12-31 | $454.47 Million | +30.11% |
| 2019-12-31 | $349.30 Million | +10.69% |
| 2018-12-31 | $315.57 Million | +6.54% |
| 2017-12-31 | $296.20 Million | +42.45% |
| 2016-12-31 | $207.94 Million | +9.83% |
| 2015-12-31 | $189.32 Million | -0.16% |
| 2014-12-31 | $189.63 Million | +2.92% |
| 2013-12-31 | $184.25 Million | -3.90% |
| 2012-12-31 | $191.72 Million | +49.95% |
| 2011-12-31 | $127.86 Million | +4.36% |
| 2010-12-31 | $122.52 Million | -3.52% |
| 2009-12-31 | $126.99 Million | -3.74% |
| 2008-12-31 | $131.92 Million | -21.17% |
| 2007-12-31 | $167.35 Million | +6.89% |
| 2006-12-31 | $156.57 Million | +19.75% |
| 2005-12-31 | $130.75 Million | +48.47% |
| 2004-12-31 | $88.06 Million | +2.22% |
| 2003-12-31 | $86.15 Million | +141.07% |
| 2002-12-31 | $35.74 Million | -4.15% |
| 2001-12-31 | $37.28 Million | -1.20% |
| 2000-12-31 | $37.74 Million | +252.67% |
| 1999-12-31 | $10.70 Million | +2.88% |
| 1998-12-31 | $10.40 Million | -38.82% |
| 1997-12-31 | $17.00 Million | -58.44% |
| 1996-12-31 | $40.90 Million | +35.88% |
| 1995-12-31 | $30.10 Million | +22.36% |
| 1994-12-31 | $24.60 Million | +74.47% |
| 1993-12-31 | $14.10 Million | -10.19% |
| 1992-12-31 | $15.70 Million | +3.29% |
| 1991-12-31 | $15.20 Million | +137.50% |
| 1990-12-31 | $6.40 Million | -20.99% |
| 1989-12-31 | $8.10 Million | -- |
About OraSure Technologies Inc
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapi… Read more